IMO, the Lonsec Approved rating won't get them as far as they think. That is their lowest investment grade rating. Most dealer groups only accept Recommended and above.
Of the two researchers with the most market share to advisors (that cover products like this because Morningstar won't), one says Approved and the other is Not Investment Grade.
So it's down to direct investors/SMSFs. They have got a long way to go.
- Forums
- ASX - By Stock
- DCL
- Ann: Pre-Quotation Disclosure Notice With Various Confirmations
Ann: Pre-Quotation Disclosure Notice With Various Confirmations, page-10
-
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DCL (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.790M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DCL (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online